Transdermal delivery of butamben using elastic and conventional liposomes

Journal of Liposome Research

Volumn 23, Issue 3, 2013, Pages 228-234

  Cereda, Cintia Maria Saia ^a   Franz Montan, Michelle ^a   Da Silva, Camila Morais Gonçalves ^a   Casadei, Bruna Renata ^a   Domingues, Cleyton Crepaldi ^a   Tofoli, Giovana Radomille ^b   De Araujo, Daniele Ribeiro ^c   De Paula, Eneida ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE SÃO FRANCISCO   (Brazil)

^c UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

Butamben; Liposome; Nanotechnology; Permeation; Sustained release

Indexed keywords

BUTYLCAINE; LIPOSOME; STEARIC ACID;

ANISOTROPY; ARTICLE; DRUG ANALYSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLUORESCENCE; IN VITRO STUDY; MEMBRANE STRUCTURE; NANOENCAPSULATION; PARTICLE SIZE; PARTITION COEFFICIENT; PRIORITY JOURNAL; SKIN PERMEABILITY; SURFACE CHARGE; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ANESTHETICS, LOCAL; ANIMALS; BENZOCAINE; DRUG COMPOUNDING; ELASTICITY; FLUORESCENCE POLARIZATION; GELS; LIPOSOMES; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SKIN ABSORPTION; SWINE;

EID: 84880486313     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2013.796975     Document Type: Article

References (47)

1. Boinpally RR, Zhou SL, Poondru S, et al. (2003). Lecithin vesicles for topical delivery of diclofenac. Eur J Pharm Biopharm 56:389-92.
2. Bouwstra JA, Graaff A, Groenink W, Honeywell L. (2002). Elastic vesicles: interaction with human skin and drug transport. Cell Mol Biol Lett 7:222-3.
3. Cereda CMS, Araújo DR, Brunetto GB, de Paula E. (2004). Liposomal prilocaine: preparation, characterization and in vivo evaluation. J Pharm Pharmaceut Sci 7:235-40.
4. Cereda CMS, Araújo DR, Brunetto GB, de Paula E. (2006). Liposomal formulations of prilocaine, lidocaine and mepivacaine prolong analgesic duration. Can J Anaest 53:1092-7.
5. Cereda CMS, Tofoli GR, Brito-Junior RB, et al. (2008). Stability and local toxicity evaluation of a liposomal prilocaine formulation. J Liposome Res 18:329-39.
6. Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226-32.
7. Cevc G, Blume G. (2004). Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 1663: 61-73.
8. Cevc G, Gebauer D, Stieber J, et al. (1998). Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368:201-15.
9. de Araújo DR, Padula C, Cereda CMS, et al. (2010). Bioadhesives films containing benzocaine: correlation between "in vitro" permeation and in vivo local anesthetic effect. Pharm Res 27:1677-86.
10. de Paula E, Cereda CMS, Tofoli GR, et al. (2010). Drug delivery systems for local anesthetics. Rec Pat Drug Deliv Formulat 4:23-34.
11. de Paula E, Schreier S. (1995). Use of a novel method for determination of partition coefficient to compare the effect of local anesthetics on membrane structure. Biochim Biophys Acta 1240:25-33.
12. Dubey V, Mishra D, Dutta T, et al. (2007). Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 123:148-54.
13. El Maghraby GM, Williams AC, Barry BW. (1999). Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 51:1123-34.
14. El Maghraby GM, Williams AC, Barry BW. (2000). Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 204:159-69.
15. El Maghraby GM, Williams AC, Barry BW. (2001). Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol 53:1069-77.
16. Ellena JF, Archer SJ, Dominey RN, et al. (1988). Localizing the nitroxide group of fatty-acid and voltage-sensitive spin-labels in phopholipid-bilayers. Biochim Biophys Acta 940:63-70.
17. Flores-Murrieta FJ, Hoyo-Vadillo C, Hong E, Castañeda-Hernandez G. (1989). Assay of ambroxol in human plasma by high-performance liquid chromatography with amperometric detection. J Chromatogr 490:464-9.
18. Franz-Montan M, Cereda CMS, Gaspari A, et al. (2013). Liposomalbenzocaine gel formulation: correlation between in vitro assays and in vivo topical anesthesia in volunteers. J Liposome Res 23:54-60.
19. Franz-Montan M, Silva AL, Fraceto LF, et al. (2010). Liposomal encapsulation improves the duration of soft tissue anesthesia but does not induce pulpal anesthesia. J Clin Anesth 22:313-17.
20. Gillet A, Lecomte F, Hubert P, et al. (2011). Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm 79:43-53.
21. Godici PE, Landsberger FR. (1974). Dynamics structure of lipidmembranes-C13 nuclear magnetic resonance study using spin labels. Biochemistry 13:362-8.
22. Grant GJ, Barenholz Y, Bolotin EM, et al. (2004). A novel liposomal bupivacaine formulation to produce ultra long-acting analgesia. Anesthesiology 101:133-7.
23. Griffith OH, Jost OP. (1976). Spin labels in biological membranes. In: Berliner LJ, ed. Spin Labeling: Theory and Applications. New York: Academic Press, 454-523.
24. Grillo R, Melo NFS, de Araujo DR, et al. (2009). Validation of an HPLC method for quantitative determination of benzocaine in PHBVmicroparticles and PLA-nanoparticles. Lat Am J Pharm 28:393-9.
25. Grouls RJE, Ackerman EW, Korsten HHM, et al. (1997). Partition coefficients (n-octanol/water) of N-butyl-p-aminobenzoatte and other local anesthetics measured by reversed-phase high-performance liquid chromatography. J Chromatog B 694:421-5.
26. Honeywell-Nguyen LP, Groenink HW, Bouwstra JA. (2006). Elastic vesicles as a tool for dermal and transdermal delivery. J Liposome Res 16:273-80.
27. ICH (2005). Validation of analytical procedures: text and methodology (Q2R1). International Conference on Harmonization; November, 2005; Geneva.
28. Jain S, Tiwary AK, Sapra B, Jain NK. (2007). Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 21:E111.
29. Kuroda Y, Nasu H, Fujiwara Y, Nakagawa T. (2000). Orientations and locations of local anesthetics benzocaine and butamben in phospholipid membranes as studied by 2H NMR spectroscopy. J Membrane Biol 177:117-28.
30. Lackowicz JR. (2006). Principles of Fluorescence Spectroscopy. 3rd ed. New York: Springer.
31. López-Pinto JM, González-Rodŕguez ML, Rabasco AM. (2005). Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1-12.
32. Maestrelli F, Capasso G, Gonzalez-Rodriguez ML, et al. (2009). Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res 4:1-8.
33. Maestrelli F, González-Rodŕguez ML, Rabasco AM, et al. (2010). New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anesthetics. Int J Pharm 395:222-31.
34. Malinovsky JM, Benhamou D, Alafandy M, et al. (1997). Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits. Anesth Analg 85:1331-6.
35. Melo NFS, Grillo R, Guilherme VA, et al. (2011). Poly(lactide- coglycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity. Pharm Res 28:1984-1994.
36. Mohanraj VJ, Chen Y. (2006). Nanoparticles-a review. Trop J Pharm Res 5:561-73.
37. Mura P, Capasso G, Maestrelli F, Furlanetto S. (2008). Optimization of formulation variables of benzocaine liposomes using experimental design. J Liposome Res 18:113-25.
38. Mura P, Maestrelli F, González-Rodŕguez ML, et al. (2007). Development, characterization and in vivo evaluation of benzocaineloaded liposomes. Eur J Pharm Biopharm 67:86-95.
39. Planas ME, Gonzalez P, Rodriguez L, et al. (1992). Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth Analg 75:615-21.
40. Santana MHA, Zanchetta B. (2011). Elastic liposomes. In: Beck R, Guterres S, Pohlmann A, eds. Nanocosmetics and Nanomedicines: New Approaches for Skin Care. Berlin: Springer, 139-62.
41. Schreier S, Polnaszek CF, Smith ICP. (1978). Spin labels in membranes. Problems in practice. Biochim Biophys Acta 515:375-436.
42. Silva ALR, Franz-Montan M, Groppo FC, et al. (2008). Pharmaceutical composition comprising a local anesthetic and a carboxyvinyl polymer. Patent # WO/2008/138089.
43. Simões SI, Delgado TC, Lopes RM, et al. (2005). Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in transfersomes. J Control Release 103:419-34.
44. Strichartz GR, Sanchez V, Arthur GR, et al. (1990). Fundamental properties of local anesthetics. II. Measured octanol:buffer partition coefficients and pKa values of clinically used drugs. Anesth Analg 71: 158-70.
45. Trotta M, Peira E, Debernardi F, Gallarate M. (2002). Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241: 319-27.
46. Trotta M, Peira E, Carlotti ME, Gallarate M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270: 119-25.
47. Weiniger CF, Golovanevski M, Sokolsky-Papkov M, Domb AJ. (2010). Review of prolonged local anesthetic action. Expert Opin Drug Deliv 7:737-52.